Defunct Company
Total Trials
21
As Lead Sponsor
As Collaborator
0
Total Enrollment
5,334
NCT00485017
Efficacy and Safety of THR-4109 in Obese Subjects
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 31, 2007
Completion: Jun 30, 2008
NCT00854113
Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers
Phase: Phase 1
Start: Feb 28, 2009
Completion: Jul 31, 2009
NCT00924053
Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes
Start: Jun 30, 2009
NCT01029704
Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus
Start: Dec 31, 2009
Completion: Jul 31, 2010
NCT01155531
Safety & Tolerability of a Combination of Antidepressant and Peptic Ulcer Drug in Overweight Healthy Subjects
Start: May 31, 2010
Completion: Aug 31, 2010
NCT01377844
Efficacy and Safety of EGT0001442 in Patients With Type 2 Diabetes Mellitus
Start: Dec 31, 2011
Completion: Dec 31, 2013
NCT02390050
A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus
Start: May 12, 2015
Completion: Jun 3, 2016
NCT02558296
Bexagliflozin Efficacy and Safety Trial
Phase: Phase 3
Start: Oct 31, 2015
Completion: Oct 23, 2019
NCT02715258
Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes
Start: Mar 31, 2016
Completion: Apr 30, 2017
NCT02820298
Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects
Start: Jun 20, 2016
Completion: Aug 29, 2016
NCT02769481
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Start: Aug 15, 2016
Completion: Jun 14, 2019
NCT02836873
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
Start: Sep 23, 2016
Completion: Jan 11, 2018
NCT02956044
Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin
Start: Nov 30, 2016
Completion: Mar 31, 2017
NCT03167411
Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
Start: May 24, 2017
Completion: Jun 29, 2017
NCT03197324
Bexagliflozin Drug/Drug Interaction Study With Digoxin
Start: Jul 24, 2017
Completion: Sep 17, 2017
NCT03296800
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
Start: Sep 27, 2017
Completion: Dec 6, 2017
NCT03115112
Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Start: Oct 12, 2017
Completion: Oct 31, 2018
NCT03514641
An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension
Phase: Phase 2/3
Start: Oct 18, 2017
Completion: Nov 30, 2018
NCT03259789
Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Start: Nov 28, 2017
Completion: Jan 23, 2019
NCT03557658
Safety and Efficacy of Bexagliflozin in Subjects With Moderate Hepatic Impairment
Start: Jul 26, 2018
Completion: Dec 26, 2018
NCT03417076
Absolute Bioavailability Study With Bexagliflozin
Start: Aug 1, 2018
Completion: Sep 16, 2018